The 2.4 mg maintenance dose is close to the 1 mL capacity of a standard U-100 insulin syringe, which is why some community sources reconstitute cagrilintide at higher concentration (e.g., 5 mg in 1.5 mL 3.33 mg/mL 2.4 mg = 0.72 mL = 72 units) to keep dose volume manageable
Phase 3 (ongoing): the TRIUMPH program is the pivotal Phase 3 effort
Waist measurements and monthly photos tell the real story
This widespread receptor distribution has prompted investigation into potential pleiotropic effects, including anti-inflammatory properties that may contribute to their broader clinical benefits in cardiometabolic disease
For men, this metric often shows dramatic improvement and reflects the visceral fat loss that carries significant health benefits
Potential additional indications being studied: Type 2 diabetes management Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD) Knee osteoarthritis Obstructive sleep apnea Cardiovascular and renal outcomes in obesity How do you get retatrutide right now